News & Events

Parkinson’s UK and Critical Path Institute Launch the Critical Path for Parkinson’s (CPP) Consortium

October 14, 2015 Parkinson’s UK and Critical Path Institute Launch the Critical Path for Parkinson’s (CPP) Consortium Data from past Parkinson’s trials will be collected, standardized, and integrated, in order to inform new approaches to designing clinical trials focused on early-stage Parkinson’s. London and Tucson – October 14, 2015 – Parkinson’s UK, one of the […]

PD Imaging Biomarker Team at European Medicines Agency (EMA)

Experts of the Parkinson’s disease imaging biomarker team participated in a Scientific Advice meeting at the European Medicines Agency on October 7th 2015. The purpose of this meeting was to review the evidence provided to the Agency that supports the use of Molecular Imaging of the Dopamine Transporter as an enrichment biomarker in clinical trials […]

Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers

April 13, 2015 Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers FDA and EMA Letters of Support Suggest Valuable Research Potential TUCSON, Ariz., April 8, 2015 – The Critical Path Institute (C-Path) announced today that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have issued Biomarker […]